Category Archives: ATI-502

Brief Aclaris ATI-502 Topical Update

Yesterday, Aclaris Therapeutics provided an update regarding its  ATI-502 JAK inhibitor product for the topical treatment of androgenetic alopecia (AGA). It seems like this product was called ATI-50002 in the past? In any event, the main quote:

“AGA-201 Topical – Completed enrollment of this ongoing Phase 2 open-label clinical trial of ATI-502 for the topical treatment of androgenetic alopecia (AGA), also known as male/female pattern hair loss. This trial will evaluate the safety and efficacy of ATI-502 on the regrowth of hair in 31 patients with AGA, and data are expected in the first half of 2019”.

Based on the hype several years ago, I would have thought that Aclaris would be finishing Phase 2 trials by year-end 2018. Will nevertheless take this news in stride.

Big year in 2019 to weed out the players from the fakers.